DK1781814T3 - Fremgangsmåder og kit til prognose af brystkræft - Google Patents

Fremgangsmåder og kit til prognose af brystkræft

Info

Publication number
DK1781814T3
DK1781814T3 DK05763127.7T DK05763127T DK1781814T3 DK 1781814 T3 DK1781814 T3 DK 1781814T3 DK 05763127 T DK05763127 T DK 05763127T DK 1781814 T3 DK1781814 T3 DK 1781814T3
Authority
DK
Denmark
Prior art keywords
breast cancer
likelihood
patient
molecular
prognosis
Prior art date
Application number
DK05763127.7T
Other languages
English (en)
Inventor
Wen Guo Jiang
Original Assignee
Cardiff Biolog Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0417740A external-priority patent/GB0417740D0/en
Priority claimed from GB0426777A external-priority patent/GB0426777D0/en
Application filed by Cardiff Biolog Ltd filed Critical Cardiff Biolog Ltd
Application granted granted Critical
Publication of DK1781814T3 publication Critical patent/DK1781814T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Prostheses (AREA)
DK05763127.7T 2004-08-10 2005-07-27 Fremgangsmåder og kit til prognose af brystkræft DK1781814T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0417740A GB0417740D0 (en) 2004-08-10 2004-08-10 Methods and kit for the prognosis of breast cancer
GB0426777A GB0426777D0 (en) 2004-12-07 2004-12-07 Methods and kit for the prognosis of breast cancer
PCT/GB2005/002971 WO2006016110A1 (en) 2004-08-10 2005-07-27 Methods and kit for the prognosis of breast cancer

Publications (1)

Publication Number Publication Date
DK1781814T3 true DK1781814T3 (da) 2010-05-03

Family

ID=35044601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05763127.7T DK1781814T3 (da) 2004-08-10 2005-07-27 Fremgangsmåder og kit til prognose af brystkræft

Country Status (14)

Country Link
US (1) US20100035240A1 (da)
EP (1) EP1781814B3 (da)
JP (2) JP5117852B2 (da)
CN (1) CN102443627B (da)
AT (1) ATE454474T1 (da)
AU (1) AU2005271113B2 (da)
CA (1) CA2576113A1 (da)
DE (1) DE602005018789D1 (da)
DK (1) DK1781814T3 (da)
ES (1) ES2339132T7 (da)
GB (1) GB2430741A (da)
MX (1) MX2007001640A (da)
PT (1) PT1781814E (da)
WO (1) WO2006016110A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497292B2 (en) 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
WO2008060369A2 (en) * 2006-09-29 2008-05-22 Translational Therapeutics, Inc. Eif4e regulon-based diagnostics
KR100786759B1 (ko) * 2006-07-07 2007-12-18 김현기 Ｈｃｃｒ-1을 포함하는 유방암 예후 마커 및 비만 유도조성물
CN1919874B (zh) * 2006-09-18 2010-09-08 中国人民解放军军事医学科学院生物工程研究所 一种抗尿激酶型纤溶酶激活剂受体的抗体样分子ATF-Fc融合蛋白及其用途
WO2008138868A2 (en) * 2007-05-09 2008-11-20 Traslational Cancer Drugs Pharma, S.L. In vitro diagnosis and/or prognosis of cancer by the analysis of gtpase protein expression
WO2008150512A2 (en) * 2007-06-04 2008-12-11 University Of Louisville Research Foundation, Inc. Methods for identifying an increased likelihood of recurrence of breast cancer
ES2338843B1 (es) * 2008-07-02 2011-01-24 Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas Huella genomica de cancer de mama.
US20100081666A1 (en) * 2008-07-14 2010-04-01 Wyeth Src activation for determining cancer prognosis and as a target for cancer therapy
US8735082B2 (en) 2008-11-10 2014-05-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene signature for predicting prognosis of patients with solid tumors
GB0821787D0 (en) * 2008-12-01 2009-01-07 Univ Ulster A genomic-based method of stratifying breast cancer patients
WO2010128158A1 (en) * 2009-05-08 2010-11-11 Novartis Ag Diagnostic biomarkers for fibrotic disorders
WO2011122857A2 (ko) * 2010-03-30 2011-10-06 서울대학교 산학협력단 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
WO2012131564A1 (en) * 2011-03-27 2012-10-04 Oncostem Diagnostics Pvt. Ltd. Markers for identifying tumor cells, methods and kit thereof
EP2723924A4 (en) * 2011-06-22 2015-03-25 Oncocyte Corp METHOD AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER
EP2751570A4 (en) * 2011-08-31 2015-08-12 Oncocyte Corp METHOD AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF CANCER
US8859202B2 (en) 2012-01-20 2014-10-14 The Ohio State University Breast cancer biomarker signatures for invasiveness and prognosis
FR2988479B1 (fr) * 2012-03-23 2014-12-19 Hospices Civils Lyon Procede de determination de la susceptibilite aux infections nosocomiales
KR101672531B1 (ko) * 2013-04-18 2016-11-17 주식회사 젠큐릭스 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도
CN103235141A (zh) * 2013-04-27 2013-08-07 上海交通大学医学院附属新华医院 Atf3用于预测膀胱癌转移和判断预后的应用
KR101548830B1 (ko) * 2013-12-30 2015-08-31 가천대학교 산학협력단 줄기세포 배양방법을 이용하여 발굴된 유방암 줄기세포 마커를 이용한 유방암 예후 예측용 조성물
WO2015105190A1 (ja) * 2014-01-10 2015-07-16 学校法人順天堂 子宮体がんのリンパ節転移能の評価方法
PL3137595T3 (pl) * 2014-04-29 2019-09-30 Novartis Ag Nowe komórki kręgowców i sposoby ekspresji rekombinowanej polipeptydu będącego przedmiotem zainteresowania
CN105986024B (zh) * 2015-02-27 2019-10-25 复旦大学附属肿瘤医院 一组用于三阴性乳腺癌预后的基因及其应用
CN104725488A (zh) * 2015-04-06 2015-06-24 苏州普罗达生物科技有限公司 关于紧密连接蛋白抑制剂多肽及其应用
CN104725487A (zh) * 2015-04-06 2015-06-24 苏州普罗达生物科技有限公司 紧密连接蛋白抑制剂多肽及其应用
CN106295244B (zh) * 2015-06-05 2019-09-17 上海交通大学医学院附属瑞金医院 肿瘤诊断标志物的筛选方法、以该方法获得的乳腺癌肺转移相关基因及其应用
EP3303387A2 (en) 2015-06-05 2018-04-11 Novartis AG Antibodies targeting bone morphogenetic protein 9 (bmp9) and methods therefor
EP3321683A4 (en) * 2015-07-09 2018-11-21 Juntendo Educational Foundation Method for evaluating lymph node metastatic potential of endometrial cancer
CN106337081B (zh) * 2016-02-02 2020-01-21 中国医学科学院肿瘤医院 FABP4基因的SNP位点rs1054135与三阴型乳腺癌预后的相关性
WO2018074865A2 (ko) * 2016-10-21 2018-04-26 서울대학교병원 유방암 예후 예측용 조성물 및 방법
EP3364190A1 (en) * 2017-02-20 2018-08-22 Panka Cancer Research AG Method of detecting cancer or cancer cells
WO2018159808A1 (ja) * 2017-03-03 2018-09-07 国立研究開発法人国立がん研究センター 抗ｉｌ－７ｒ抗体の抗体薬物コンジュゲートと、がんまたは炎症を処置することに用いるための、抗ｉｌ－７ｒ抗体と細胞傷害剤との抗体薬物コンジュゲートを含む医薬組成物
CN108504726B (zh) * 2018-03-28 2021-10-26 华南农业大学 采用amf单个孢子微量dna进行pcr预处理的方法
WO2020008097A2 (es) * 2018-07-03 2020-01-09 Universidad De Granada Método de obtención de datos útiles para predecir o pronosticar la supervivencia global y la supervivencia libre de recaídas en el cáncer y composición capaz de modular la actividad de atf4 para el tratamiento del cáncer
CN109620832B (zh) * 2019-01-14 2021-01-01 大连大学 甘氨胆酸在制备抗乳腺增生药物中的应用
KR102280672B1 (ko) * 2019-12-20 2021-07-23 주식회사 베르티스 암의 진단용 조성물
CN114758773A (zh) * 2022-05-25 2022-07-15 四川大学华西医院 一种膀胱癌免疫治疗生物标志物、免疫风险模型及其应用
CN116656820B (zh) * 2023-05-17 2025-11-18 南华大学附属第一医院 一种基于乳腺肿瘤干细胞相关基因的预后模型及其应用
CN117092336A (zh) * 2023-06-16 2023-11-21 中国医学科学院北京协和医院 血浆n4bp1、creb1、ubap2、deaf1自身抗体标志物在弥漫大b细胞淋巴瘤预后预测中的应用
WO2026015514A1 (en) * 2024-07-11 2026-01-15 The Johns Hopkins University Methods for predicting tumor behavior and metastatic risk in epithelial malignancies
CN118853892B (zh) * 2024-09-29 2024-12-06 四川大学华西医院 一种用于检测乳腺癌的血小板标志物及检测试剂盒

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
CA2279575A1 (en) * 1997-02-06 1998-08-13 Genetics Institute, Inc. Human sdf-5 protein and compositions
AU2351699A (en) * 1998-01-30 1999-08-16 Brigham And Women's Hospital The human calcium-sensing receptor in the detection and treatment of cancer
PT1131087E (pt) * 1998-11-13 2004-12-31 Curis Inc Metodos de alivio de sintomas de cancro
JP2005503760A (ja) * 2001-01-24 2005-02-10 プロテイン デザイン ラブス， インコーポレイテッド 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法
US20030064384A1 (en) * 2001-04-02 2003-04-03 Mien-Chie Hung Beta-catenin is a strong and independent prognostic factor for cancer
US20040086504A1 (en) * 2001-06-21 2004-05-06 Deepak Sampath Cyr61 as a target for treatment and diagnosis of breast cancer
AU2002232563A1 (en) * 2001-12-05 2003-06-23 Genzyme Corporation Compounds for therapy and diagnosis and methods for using same
AU2002366712A1 (en) * 2001-12-20 2003-07-09 The Regents Of The University Of California Genetic markers and methods for the diagnosis, treatment and prevention of tumor metastasis
US20030186248A1 (en) * 2002-03-29 2003-10-02 Erlander Mark G. Interpreting cytological specimens via molecular histological signatures
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure

Also Published As

Publication number Publication date
GB0701676D0 (en) 2007-03-14
DE602005018789D1 (de) 2011-05-26
ES2339132T7 (es) 2012-03-16
ES2339132T3 (es) 2010-05-17
EP1781814B3 (en) 2011-08-31
AU2005271113B2 (en) 2010-12-09
CA2576113A1 (en) 2006-02-16
AU2005271113A1 (en) 2006-02-16
MX2007001640A (es) 2007-07-25
HK1103422A1 (en) 2007-12-21
JP5117852B2 (ja) 2013-01-16
CN102443627B (zh) 2014-10-29
GB2430741A (en) 2007-04-04
JP2008508895A (ja) 2008-03-27
WO2006016110A8 (en) 2006-08-24
PT1781814E (pt) 2010-04-12
EP1781814B1 (en) 2010-01-06
JP2012024095A (ja) 2012-02-09
WO2006016110A1 (en) 2006-02-16
CN102443627A (zh) 2012-05-09
EP1781814A1 (en) 2007-05-09
JP5634360B2 (ja) 2014-12-03
ATE454474T1 (de) 2010-01-15
US20100035240A1 (en) 2010-02-11

Similar Documents

Publication Publication Date Title
DK1781814T3 (da) Fremgangsmåder og kit til prognose af brystkræft
UA110790C2 (uk) Спосіб передбачування рецидиву раку молочної залози при ендокринному лікуванні
Gaedcke et al. Mutated KRAS results in overexpression of DUSP4, a MAP‐kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
Chen et al. TOP2A, HELLS, ATAD2, and TET3 are novel prognostic markers in renal cell carcinoma
Wang et al. A competing endogenous RNA network reveals novel potential lncRNA, miRNA, and mRNA biomarkers in the prognosis of human colon adenocarcinoma
Fenger et al. Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis
Schramm et al. Next‐generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN‐amplified neuroblastoma
Liu et al. Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray
ATE523786T1 (de) In-vitro-verfahren zur prognose des fortschreitens einer krebserkrankung und des ausgangs für einen patienten sowie verfahren zur durchführung des verfahrens
Shah et al. The landscape of alternative splicing in buccal mucosa squamous cell carcinoma
WO2008117314A3 (en) Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
Gao et al. Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer
WO2005116259A3 (en) Use of gene expression profiling to predict survival in cancer patient
Chen et al. Aberrant methylation of FBN2 in human non-small cell lung cancer
DE602005009406D1 (de) Computerimplementiertes verfahren und computergestütztes system zur validierung von dna-sequenzierungsdaten
Jung et al. Increased expression levels of AURKA and KIFC1 are promising predictors of progression and poor survival associated with gastric cancer
Wang et al. hsa_circ0021347 as a Potential target regulated by B7‐H3 in modulating the malignant characteristics of osteosarcoma
Zhang et al. Association of miR‐1247‐5p expression with clinicopathological parameters and prognosis in breast cancer
EP1987165A4 (en) Gene with influence on the human memory
WO2014173905A3 (en) Methods and kits for prognosis of stage i nsclc by determining the methylation pattern of cpg dinucleotides
Lin et al. The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer
RU2016131028A (ru) Композиции, содержащие асимметричную интерферирующую рнк, которые подвергают сайленсингу k-ras, и способы их применения
CN108174608B (zh) 用于确定患有i期和ii期透明细胞型肾癌瘤的肾癌患者的复发风险的预后方法以及其试剂盒
Prasad et al. Pathway based prognostic gene expression profile of buccal and gingivo‐buccal oral squamous cell carcinoma in smokeless tobacco chewers
Luo et al. Comprehensive analysis of N1-methylandenosine regulators and m1A-related mRNAs and lncRNAs as prognostic factors in bladder cancer